Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight [Phase 2]
This clinical trial update announces a Phase 2 study evaluating the efficacy and safety of Maridebart Cafraglutide in adults with obesity or…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Early Tracking of Childhood Health Determinants (ETCHED) Study
Clinical trial update for the ETCHED study sponsored by NIDDK. It investigates early determinants of childhood health related to diabetes me…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver Disease
This clinical trial update describes dynamic post-prandial metabolism in patients with non-alcoholic fatty liver disease; the study status i…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters. [NA]
This completed clinical trial examines whether pairing a Mediterranean diet with a structured physical activity program influences non-alcoh…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic Steatosis [NA]
Recruitment is underway for a study examining how acute exercise affects endogenous glucose production in people with type 2 diabetes and he…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH [Phase 3]
GlaxoSmithKline is conducting a Phase 3 pivotal trial to evaluate Efimosfermin Alfa in participants with biopsy-confirmed F2- or F3-stage MA…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH [Phase 3]
GlaxoSmithKline is conducting a Phase 3 study to evaluate the safety and tolerability of Efimosfermin Alfa Injection in participants with F2…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD [NA]
A completed clinical trial evaluated whether tomato consumption influences liver steatosis, intestinal function, and glucose/lipid metabolis…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
ClinicalTrials.gov update announcing an actively recruiting study of chronic liver diseases associated with alcohol use and metabolic syndro…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Bicalutamide Therapy in Young Women With NAFLD and PCOS [Phase 1]
Clinical trial update for a Phase 1 study evaluating bicalutamide therapy in young women with Non-alcoholic fatty liver disease and Polycyst…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease [Phase 2]
Phase 2 study evaluating the effects of semaglutide in obese youth with prediabetes or new-onset type 2 diabetes and non-alcoholic fatty liv…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Dietary Allowance of Methyl Donor Nutrients to Minimize Risks of Non-alcoholic Fatty Liver Progression [NA]
A completed clinical trial evaluated whether dietary intake of methyl donor nutrients can reduce the risk of progression in non-alcoholic fa…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease [EARLY_Phase 1]
Phase 1 study updated on the gut, liver, and metabolome in people with HIV and fatty liver disease; the trial is currently active but not re…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD) [Phase 1]
Phase 1 trial of LY3885125 in participants with dyslipidemia and non-alcoholic fatty liver disease was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: FibroScan-Reproducibility and Repeatability Study [NA]
A completed clinical trial assessing the reproducibility and repeatability of FibroScan measurements in patients with non-alcoholic fatty li…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Efimosfermin Alfa in Adults With Hepatic Impairment [Phase 1]
Phase 1 study evaluating efimosfermin alfa in adults with hepatic impairment, targeting non-alcoholic fatty liver disease; currently recruit…
-
EMA approval · 2026-04-09EMA Authorised: Kayshild (semaglutide) — Novo Nordisk A/S
EU medicines regulator authorised Kayshild (semaglutide) by Novo Nordisk A/S for non-alcoholic fatty liver disease and liver cirrhosis, with…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH [Phase 2]
Phase 2 clinical trial update for DD01 in overweight/obese individuals with MASLD/MASH (NAFLD/NASH), sponsored by Neuraly, Inc.; the study i…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Non-Invasive Diagnostic Tests for MASLD in Pediatric Population [NA]
Emory University is conducting an active-not-recruiting study evaluating non-invasive diagnostic tests for Metabolic Dysfunction-Associated …
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: The Correlation Between hs CRP TG Triglycerides Glucose Index in NAFLD and Liver Fibrosis
A clinical trial from Assiut University investigates the relationship between hs-CRP, triglycerides, and a glucose index with liver fibrosis…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: JiGenerations Health Cohort Study：Parental Exposure and Intergenerational Health in China
This clinical trial update describes the JiGenerations Health Cohort Study in China, examining how parental environmental exposures relate t…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Microbiome-Mediated Gut Dysfunction in Non-Alcoholic Fatty Liver Disease
This ClinicalTrials.gov entry reports a completed study examining microbiome-mediated gut dysfunction in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Siemens Biomarker Multi-modality [NA]
Recruiting update for a multi-modality biomarker clinical trial investigating fatty liver disease at Duke University.
-
CLINICAL_TRIALS withdrawal · 2026-04-01Clinical Trial Update: FCI Effectiveness in NAFLD Stratification [NA]
The clinical trial NCT05827432 evaluating FCI effectiveness in stratifying Non-Alcoholic Fatty Liver Disease has been withdrawn by the spons…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH [NA]
This clinical trial update indicates completion of a study characterizing immune semaphorin in non-alcoholic fatty liver disease and nonalco…